Patents Assigned to EIP PHARMA, LLC
  • Patent number: 11466008
    Abstract: Provided herein are co-crystal forms comprising 5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one (VX-745): and compositions thereof, useful as inhibitors of one or more protein kinases and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: October 11, 2022
    Assignee: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeffrey Douglas Wilson
  • Publication number: 20200308176
    Abstract: Provided herein are co-crystal forms, and compositions thereof, useful as inhibitors of one or more protein kinases and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: September 18, 2018
    Publication date: October 1, 2020
    Applicant: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeff Wilson
  • Patent number: 10653695
    Abstract: Disclosed are oral pharmaceutical compositions of neflamapimod that exhibit suitable exposure for administration in humans and/or that maintain a desirable dissolution profile under standard storage conditions.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: May 19, 2020
    Assignee: EIP Pharma, LLC
    Inventors: John Jahangir Alam, Jeffrey Douglas Wilson
  • Publication number: 20190381049
    Abstract: The present invention provides methods and compositions for improving episodic memory and treating dementia.
    Type: Application
    Filed: August 23, 2019
    Publication date: December 19, 2019
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Patent number: 10420770
    Abstract: The present invention provides methods and compositions for improving episodic memory and treating dementia.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: September 24, 2019
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Patent number: 9579322
    Abstract: The present invention provides methods for treating a neurological disorder.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: February 28, 2017
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Patent number: 9427438
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: August 30, 2016
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Patent number: 9427439
    Abstract: The present invention provides methods and compositions for promoting recovery of function from neurologic injury, such as ischemic injury caused by acute stroke.
    Type: Grant
    Filed: October 26, 2015
    Date of Patent: August 30, 2016
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Publication number: 20140357638
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Application
    Filed: February 27, 2014
    Publication date: December 4, 2014
    Applicant: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Patent number: 8697627
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Grant
    Filed: May 9, 2012
    Date of Patent: April 15, 2014
    Assignee: EIP Pharma, LLC
    Inventor: John Jahangir Alam
  • Publication number: 20120289511
    Abstract: The present invention provides compositions for reducing amyloid plaque burden associated with Alzheimer's disease and methods of using the same.
    Type: Application
    Filed: May 9, 2012
    Publication date: November 15, 2012
    Applicant: EIP PHARMA, LLC
    Inventor: John Jahangir Alam